FDA Inspection 1263062 — Intertek USA Inc.

Intertek USA Inc. — FEI 1000151295

The FDA completed an inspection of Intertek USA Inc. on March 7, 2025 in Whitehouse, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 7, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Whitehouse, NJ (United States)

Citations

IDCFRDescription
121 CFR 11Electronic records
110521 CFR 211.22(d)Procedures not in writing, fully followed